Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

ART Regimen Drives Metabolic Variation in Pediatric HIV

The specific antiretroviral therapy regimen—not just HIV status—profoundly shapes the metabolic landscape in virally suppressed children living with HIV.

Do Calories Still Count for Weight Loss?

Calorie counting may seem unnecessary in this era of effective weight-loss drugs, but some experts agree it still has a role to play.

Semaglutide Cuts Calories Even as Appetite Benefits Fade

Adults with overweight or obesity receiving semaglutide eat significantly fewer calories than those on placebo through week 60, despite early gains in appetite control waning after week 20.

Frequent Contraceptive Switching Tied to Semaglutide Use

Those who use hormonal birth control, particularly those who switch methods multiple times, are far more likely to take semaglutide later in life.
HTTP error: 503HTTP error: 503

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Todays Updates

Despite Medicare Coverage, Cancer Genomic Testing Still Low

Medicare coverage of next-generation sequencing may have spurred an increase in the number of patients receiving genomic tests. But uptake remains low.

Latest News

HTTP error: 503HTTP error: 503

Adults with overweight or obesity receiving semaglutide eat significantly fewer calories than those on placebo through week 60, despite early gains in appetite control waning after week 20.
HTTP error: 503HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503

Spermidine Intake Tied to Liver Health in Obesity and MetS

An increase in dietary spermidine intake over 1 year is associated with improvements in hepatic function and cardiometabolic health in older adults with overweight or obesity and metabolic syndrome.
HTTP error: 503

SGLT2-GLP-1 Combo Little Better Than Monotherapy in T2D

Using both SGLT2 inhibitors and GLP-1 receptor agonists is no more effective than using either drug alone in patients with type 2 diabetes, a new meta-analysis suggests.
HTTP error: 503

5 Common Lab Results: Why Context Matters

Common laboratory tests can mislead when interpreted without clinical context, highlighting why appropriate test selection matters as much as the results themselves.

Lilly Announces More Next-gen Obesity Drug Data, Plans Q1 2027 FDA Application

Eli Lilly said on Thursday that two more Phase 3 trials of its experimental obesity drug retatrutide showed positive results and it plans to submit ⁠an application to the...

Efforts Address Immune Suppression in Islet Cell Transplants

Updates suggest progress in the development of less-toxic regimens, and in gene editing to eliminate the need for immune suppression entirely.

Faricimab Reduces Shots, Improves Vision for Retinal Disease

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Food Addiction Can Derail Success After Bariatric Surgery

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

Will Semaglutide Prices Drop After 2026 Patent Expirations?

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping Patients With Diabetes Utilize Technology

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.
HTTP error: 503HTTP error: 503

Compounded GLP-1s Still Widespread Despite Shortage Fix

The compounded GLP-1 market continues, even though some suppliers lack sterile-compounding licenses or have faced disciplinary action, and many add ingredients such as B vitamins.

Alcohol and Marijuana Use in Type 1 Diabetes: What to Know

People with type 1 diabetes are just as likely to use substances as the rest of the population, so they need to be aware of the risks and how to mitigate them.

Recommended News For You

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

novel technique for early myelodysplastic syndrome relapse detection in blood cancer patients.

The origin of BPH and prostate cancer in different prostate zones and the impact on the incidence of prostate cancer

New analysis helps discern benign from malignant thyroid growths

Glioblastoma cells can 'unstick' from their neighbors to become more deadly

Clinical trial is testing whether heavy lifting could combat cancer side effects

In 18 States, alcohol exclusion laws are still in effect.

Recommended Articles For You

Case Study: Genomic Medicine in Precision Oncology 

Chronic Cancer Survivorship: Managing Long-Term Outcomes with Precision Care 

Understanding Histiocytosis: Symptoms, Causes, and Treatment Options 

Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

2.

Papillary thyroid cancer: New markers offer hope for tailored treatment

3.

What Comes After Cancer?

4.

FDA Expands Durvalumab Label to Operable Lung Cancer

5.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

1.

Finding Support: Connecting with the Vitiligo Community

2.

Essential Updates in Hematology in Daily Practice

3.

Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers

4.

Living Better With Advanced Cancer Through Supportive Care

5.

Understanding Epoetin and Its Role in Treating Chronic Kidney Disease 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases

2.

Updates on Standard V/S High Risk Myeloma Treatment

3.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?

4.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot